Cobblestone Capital Advisors LLC NY lessened its position in Express Scripts Holding Co (NASDAQ:ESRX) by 73.0% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 28,805 shares of the company’s stock after selling 78,046 shares during the period. Cobblestone Capital Advisors LLC NY’s holdings in Express Scripts were worth $2,737,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in the business. Landaas & Co. WI ADV purchased a new position in shares of Express Scripts during the second quarter valued at approximately $102,000. Kaizen Advisory LLC boosted its position in shares of Express Scripts by 147.6% during the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after buying an additional 800 shares during the last quarter. Adviser Investments LLC boosted its position in shares of Express Scripts by 321.9% during the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after buying an additional 1,130 shares during the last quarter. TRUE Private Wealth Advisors purchased a new position in shares of Express Scripts during the third quarter valued at approximately $115,000. Finally, Sun Life Financial INC boosted its position in shares of Express Scripts by 758.8% during the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock valued at $117,000 after buying an additional 1,343 shares during the last quarter. 83.15% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Mahon Thomas P. Mac sold 5,234 shares of Express Scripts stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total value of $520,783.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.79% of the stock is currently owned by insiders.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.42 by $0.01. The company had revenue of $25.56 billion during the quarter, compared to analysts’ expectations of $25.11 billion. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.51 earnings per share. As a group, equities research analysts predict that Express Scripts Holding Co will post 9.08 earnings per share for the current year.
ESRX has been the topic of a number of recent analyst reports. BidaskClub upgraded Express Scripts from a “sell” rating to a “hold” rating in a report on Tuesday, July 31st. William Blair upgraded Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Royal Bank of Canada lifted their price target on Express Scripts to $94.00 and gave the stock an “outperform” rating in a report on Monday, August 27th. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, September 17th. Finally, Credit Suisse Group lowered Express Scripts from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $90.73.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
See Also: Quiet Period
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.